NRX Pharmaceuticals, Inc. (NRXP) Revenue (2025 - 2026)

NRX Pharmaceuticals (NRXP) posted quarterly Revenue of $1.1 million for Q1 2026, up 14.82% sequentially from $958000.0 in Q4 2025.

NRX Pharmaceuticals, Inc. (NRXP) Revenue (2025 - 2026) Analysis & Trends

NRX Pharmaceuticals has disclosed Revenue across 2 years of filings, most recently posting $1.1 million for Q1 2026.

In Q1 2026, Revenue changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
Revenue improved to $1.1 million in Q1 2026, from $958000.0 in the prior quarter.
Over the last five years, Revenue for NRXP reached as high as $1.1 million in Q1 2026 and fell as low as $242000.0 in Q3 2025.

Download Data